Skip to NavigationSkip to content


A new and inexpensive malaria treatment developed by GlaxoSmithKline in collaboration with the World Health Organisation has been approved in the UK.
Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.
A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms of hormone replacement therapy.
Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.
Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical development.
US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment for...
The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance for their merger.
AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA...
Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US.
Cash strapped UK biotech company Xenova is to buy rivals KS Biomedix to create a merged oncology-focused business.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches